Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Summary of the distribution of plasmid sizes, incompatibility groups and transconjugants in relation to the resistance phenotypes identified

From: Plasmid profiling and incompatibility grouping of multidrug resistant Salmonella enterica serovar Typhi isolates in Nairobi, Kenya

Resistance phenotype Plasmid size 42 MDa
N (%)
Plasmid size 98 MDa
N (%)
Incompatibility groups (N) Resistance pattern of transconjugants (N)
2004 2005 2006
AMC,TET,C,AMP (N = 10) 1 (1.0%) 4 (4.1%) HI(4) AMC,TET,C,AMP(5)
TET,C,AMP(1)
AMC,AMP(1)
TET(1)
NT(2)
CF,TET,C,AMP (N = 2) 0 (0.0%) 2 (2.0%) HI(1) HI(1) TET,C,AMP(1)
TET,AMP (1)
NT(1)
TET,C,AMP (N = 71) 52 (53.0%) 70 (71.4%) HI(25), FIC(6), I(1) HI(24), FIC(4), P(1) HI(17), FIC(3) TET,C,AMP(23)
TET,AMP(4)
C,AMP(1)
TET(4)
C(2)
AMP(1)
NT(21)
Others (N = 11) 0 (0.0%) 2 (2.0%) HI(1)
  1. AMP ampicillin, AMC amoxycillin–clavulanic acid, CF ciprofloxacin, C chloramphenicol, TET tetracycline, NT not transferable